Q1 2026 Maravai LifeSciences Holdings Inc Earnings Call Transcript
Hello and welcome everyone joining today's Maravai LifeSciences Q1 2026 earnings call. (Operator Instructions) Please note this call is being recorded. We are standing by if you should need any assistance.
It is now my pleasure to turn the meeting over to Deb Hart, Head of Investor Relations. Please go ahead.
Good afternoon, everyone. Thanks for joining us for our first-quarter 2026 earnings call. The press release and slides accompanying today's call are posted on our website and available at investors.maravai.com.
As you can see from the agenda on slide 2, our CEO, Bernd Brust, will provide a business update; and our CFO, Raj Asarpota, will review our financial results. Dr. Chanfeng Zhao, our Chief Scientific Officer, will join us for the Q&A session.
Management will make forward-looking statements and refer to GAAP and non-GAAP financial measures during today's call. It's possible that actual results could differ from expectations. We refer you to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
